Published in Bull Cancer on March 01, 2004
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet (2006) 1.17
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet (2011) 0.89
Self-reported mammography use following BRCA1/2 genetic testing may be overestimated. Fam Cancer (2012) 0.87
The challenge of developing evidence-based genetics health care in practice. Fam Cancer (2006) 0.83
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet (2011) 0.82
Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. Fam Cancer (2010) 0.80
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer (2006) 0.80
BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. PLoS One (2015) 0.79
Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges. Fam Cancer (2006) 0.79
Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method. Eur J Hum Genet (2010) 0.75
Hormone replacement therapy after prophylactic adnexectomy. Hered Cancer Clin Pract (2005) 0.75
[Screening mammography of women with a hereditary predisposition to cancer of the breast]. Bull Cancer (2004) 0.75
Angelina and Brad effect. Fam Cancer (2016) 0.75
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome. Fam Cancer (2012) 0.75
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res (2005) 5.70
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA (2011) 4.84
Quantitative assessment of breast lesion viscoelasticity: initial clinical results using supersonic shear imaging. Ultrasound Med Biol (2008) 4.15
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet (2008) 3.41
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol (2009) 2.94
Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology (2012) 2.94
Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. Radiology (2010) 2.60
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ (2012) 2.44
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst (2006) 2.25
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res (2004) 2.17
A six-gene signature predicting breast cancer lung metastasis. Cancer Res (2008) 2.09
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat (2011) 1.89
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. J Clin Oncol (2007) 1.83
Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis. J Natl Cancer Inst (2006) 1.80
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat (2012) 1.77
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes. Ann Surg Oncol (2004) 1.75
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer. JAMA (2005) 1.68
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood (2009) 1.65
Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer. J Clin Oncol (2009) 1.62
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet (2010) 1.56
Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol Oncol (2005) 1.49
A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol (2005) 1.41
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg (2003) 1.40
Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res (2012) 1.38
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res (2012) 1.38
First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients. Gynecol Oncol (2004) 1.37
Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev (2007) 1.36
Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol (2005) 1.32
Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol (2007) 1.32
Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res (2008) 1.31
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol (2013) 1.29
Laparoscopic sacrocolpopexy with two separate meshes along the anterior and posterior vaginal walls for multicompartment pelvic organ prolapse. J Am Assoc Gynecol Laparosc (2004) 1.28
Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol (2010) 1.28
Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol (2005) 1.27
Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet (2002) 1.26
Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 3-year prospective follow-up study. Int Urogynecol J (2010) 1.20
Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res (2004) 1.18
Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg (2003) 1.13
Moesin expression is a marker of basal breast carcinomas. Int J Cancer (2007) 1.09
Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer (2010) 1.09
Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity. Ann Surg Oncol (2007) 1.08
Patients' characteristics and rate of Internet use to obtain cancer information. J Public Health (Oxf) (2006) 1.08
Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One (2008) 1.07
Parameters guiding selection of best embryos for transfer after cryopreservation: a reappraisal. Hum Reprod (2002) 1.07
Outcomes of stapled transanal rectal resection vs. biofeedback for the treatment of outlet obstruction associated with rectal intussusception and rectocele: a multicenter, randomized, controlled trial. Dis Colon Rectum (2008) 1.07
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet (2013) 1.05
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol (2011) 1.02
Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol (2006) 1.02
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol (2010) 1.00
[Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas]. Bull Cancer (2004) 0.98
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One (2008) 0.98
Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP. J Med Genet (2010) 0.98
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. Int J Technol Assess Health Care (2003) 0.98
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer (2006) 0.97
Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer (2004) 0.96
Risk factors for cervical stenosis after laser cone biopsy. Eur J Obstet Gynecol Reprod Biol (2002) 0.95
Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg (2002) 0.94
Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol (2009) 0.94
Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol (2003) 0.93
Clinical audit: a useful tool for reducing severe postpartum haemorrhages? Int J Qual Health Care (2011) 0.93
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. Int J Radiat Oncol Biol Phys (2006) 0.92
Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genet Med (2010) 0.92
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene. Int J Cancer (2005) 0.91
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Res Treat (2011) 0.90
Contrast enhanced spectral mammography: better than MRI? Eur J Radiol (2012) 0.90
Pregnancy after laparoscopic sacral colpopexy: a case report. Int Urogynecol J (2011) 0.90
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Eur J Hum Genet (2011) 0.89
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet (2011) 0.89
Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Int J Radiat Oncol Biol Phys (2008) 0.89
Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol (2005) 0.89
How to optimize breast ultrasound. Eur J Radiol (2008) 0.89
Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy. Radiother Oncol (2008) 0.88
Advances in the surgical management of invasive cervical cancer. Curr Opin Obstet Gynecol (2005) 0.88
Apoptosis, onset and maintenance of spermatogenesis: evidence for the involvement of Kit in Kit-haplodeficient mice. Biol Reprod (2002) 0.87
BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis. Genet Med (2012) 0.86
Sex ratio among the offspring of BRCA mutation carriers. JAMA (2004) 0.86
Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG (2002) 0.86
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour. Oncol Rep (2006) 0.86
Sonohysterography: a prospective survey of results and complications in 81 patients. Eur J Obstet Gynecol Reprod Biol (2002) 0.85
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Res (2012) 0.85
Behavioral and economic impact of a familial history of cancers. Fam Cancer (2005) 0.85
Overnight incubation improves selection of frozen-thawed blastocysts for transfer: preliminary study using supernumerary embryos. Theriogenology (2003) 0.85
Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol (2004) 0.84
The use of laparoscopic sacrocolpopexy in the management of pelvic organ prolapse. Curr Opin Obstet Gynecol (2005) 0.84
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer. Genes Chromosomes Cancer (2010) 0.83
Accuracy of clinical data entry when using a computerized decision support system: a case study with OncoDoc2. Stud Health Technol Inform (2012) 0.83
MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results. AJR Am J Roentgenol (2005) 0.82
Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma. J Am Coll Surg (2005) 0.82
Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Int J Radiat Oncol Biol Phys (2004) 0.82
Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases. Crit Rev Oncol Hematol (2011) 0.82
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet (2011) 0.82